FLUZONE® High-Dose vaccine offers seniors superior protection against the flu
**This is a sponsored bulletin from Sanofi Pasteur**
A flu vaccine specially formulated for people 65 years and older
As we get older, our immune system weakens. Therefore, we don’t have as high an antibody response after receiving the traditional flu vaccine to help your body fight off the flu. FLUZONE® High-Dose vaccine is made for people 65+ to help promote a stronger protection against flu than a regular flu vaccine.
In adults 65 years of age and older, FLUZONE® High-Dose vaccine has been demonstrated to be significantly more effective than a standard dose vaccine in preventing confirmed influenza illness — 24.2% more effective. It has 4 times the antigen of a regular flu shot for a stronger protection against flu.
According to Canada’s National Advisory Committee on Immunization (NACI): “In older adults 65 years of age and older, given the burden of influenza A(H3N2) disease and evidence of better efficacy in this population, high dose trivalent inactivated influenza vaccine should provide superior protection compared with the standard dose intramuscular vaccine.” (i.e., FLUZONE®)
Contact your doctor, nurse, or pharmacist to see if FLUZONE® High-Dose is right for you! For more information, visit www.fluhd.ca.
This session will explore the often overlooked burden of influenza by examining its impact beyond the lung, and also discuss the evolving complement of influenza vaccines available in Canada and review NACI’s most recent position on influenza vaccines available to Canadians over 65.
As a high-dose influenza vaccine was authorized for use in Canada in 2015, this session will summarize clinical and ‘real-world’ field evidence from the US experience where this vaccine has been available since 2009 and is received by more than 60% of immunized seniors.
• Speaker: Dr. Janet McElhaney
• Moderator: Dr. David Colby
Who should attend?
When & where?
• Available On-Demand at www.canadianhealthcarenetwork.ca
• This webinar will be available on demand and free of charge until October 31st 2018.